Article
Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral…
medRxiv: the preprint server for health sciences · 2023 · Kwabena Asare, author Yukteshwar Sookrajh, author ([email protected]) Johan van der Molen, author ([email protected]) Thokozani Khubone, author ([email protected]) Lara Lewis, author ([email protected]) Richard J Lessells, author ([email protected]) Kogieleum Naidoo, author ([email protected]) Phelelani Sosibo, author ([email protected]) Rosemary van Heerden, author ([email protected]) Nigel Garrett, author ([email protected]) Jienchi Dorward, author ([email protected])
Key facts
| Title | Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral therapy in south africa: a retrospective cohort study |
|---|---|
| First author | Kwabena Asare, author Yukteshwar Sookrajh, author ([email protected]) Johan van der Molen, author ([email protected]) Thokozani Khubone, author ([email protected]) Lara Lewis, author ([email protected]) Richard J Lessells, author ([email protected]) Kogieleum Naidoo, author ([email protected]) Phelelani Sosibo, author ([email protected]) Rosemary van Heerden, author ([email protected]) Nigel Garrett, author ([email protected]) Jienchi Dorward, author ([email protected]) |
| Journal | medRxiv : the preprint server for health sciences |
| Published | Jul 10, 2023 |
| DOI | 10.1101/2023.07.07.23292347 |
| Devices mentioned | 201807 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1